Understanding the Difference Between Corneal Crosslinking and Laser Eye Surgery
Corneal Crosslinking (CXL) and laser eye surgery serve distinct purposes in eye care, and understanding their differences is essential for patients exploring treatment options.
What is Corneal Crosslinking (CXL)?
CXL is a minimally invasive treatment for keratoconus, a progressive condition that weakens the cornea, affecting approximately 1 in 1000 people. This procedure strengthens the cornea by using ultraviolet (UV) light and a riboflavin (vitamin B2) solution, triggering a chemical reaction that reinforces the corneal structure. Studies show CXL has a 98% success rate in halting keratoconus progression, making it a reliable treatment.
How is Laser Eye Surgery Different?
Unlike CXL, laser eye surgery reshapes the cornea to correct refractive errors like myopia (short-sightedness), hyperopia (long-sightedness), and astigmatism. Popular procedures include:
- LASIK & PRK – Reshape the cornea to reduce reliance on glasses or contact lenses.
- Retinal Laser Treatment – Targets retinal conditions such as diabetic eye disease.
- Laser Capsulotomy – Treats cloudiness that may develop after cataract surgery.
Is Corneal Crosslinking Safe?
Yes, CXL is a well-established procedure with a low complication rate when performed by experienced surgeons using tested protocols and advanced equipment. The risk of complications is less than 1%.
Key Takeaway
CXL strengthens the cornea for keratoconus patients, while laser eye surgery reshapes the cornea to correct vision. Both treatments are safe, effective, and offer life-changing benefits when performed by qualified ophthalmologists using advanced technology.
For more information on vision correction and corneal treatments, book a free assessment with LASERSIGHT today.
